Silvia Pasquini

1.2k total citations
43 papers, 826 citations indexed

About

Silvia Pasquini is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Silvia Pasquini has authored 43 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 27 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in Silvia Pasquini's work include Adenosine and Purinergic Signaling (28 papers), Pharmacological Receptor Mechanisms and Effects (16 papers) and Receptor Mechanisms and Signaling (11 papers). Silvia Pasquini is often cited by papers focused on Adenosine and Purinergic Signaling (28 papers), Pharmacological Receptor Mechanisms and Effects (16 papers) and Receptor Mechanisms and Signaling (11 papers). Silvia Pasquini collaborates with scholars based in Italy, United States and Canada. Silvia Pasquini's co-authors include Fabrizio Vincenzi, Katia Varani, Pier Andrea Borea, Stefania Merighi, Stefania Gessi, Chiara Contri, Annalisa Ravani, Ruggero Cadossi, Stefania Setti and Matteo Cadossi and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Silvia Pasquini

42 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Pasquini Italy 16 325 314 129 103 93 43 826
Roselyn B. Rose’Meyer Australia 17 350 1.1× 306 1.0× 185 1.4× 55 0.5× 63 0.7× 48 1.1k
Violeta N. Mutafova–Yambolieva United States 22 726 2.2× 411 1.3× 276 2.1× 80 0.8× 37 0.4× 75 1.5k
Dan L. Li United States 15 108 0.3× 545 1.7× 130 1.0× 39 0.4× 28 0.3× 26 1.3k
Pawan Faris Italy 21 181 0.6× 389 1.2× 152 1.2× 120 1.2× 49 0.5× 48 1.1k
Anthony Sharp United States 15 116 0.4× 400 1.3× 121 0.9× 224 2.2× 38 0.4× 17 847
Junwei Zeng China 18 135 0.4× 439 1.4× 154 1.2× 181 1.8× 58 0.6× 45 973
Eva Irenius Sweden 7 507 1.6× 346 1.1× 88 0.7× 63 0.6× 36 0.4× 8 746
Isabelle Pineau Canada 10 91 0.3× 343 1.1× 136 1.1× 356 3.5× 30 0.3× 10 1.4k
Michael D. Lovelace Australia 13 102 0.3× 198 0.6× 73 0.6× 118 1.1× 22 0.2× 22 708
Patricia García‐Sanz Spain 12 64 0.2× 254 0.8× 195 1.5× 97 0.9× 47 0.5× 16 725

Countries citing papers authored by Silvia Pasquini

Since Specialization
Citations

This map shows the geographic impact of Silvia Pasquini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Pasquini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Pasquini more than expected).

Fields of papers citing papers by Silvia Pasquini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Pasquini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Pasquini. The network helps show where Silvia Pasquini may publish in the future.

Co-authorship network of co-authors of Silvia Pasquini

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Pasquini. A scholar is included among the top collaborators of Silvia Pasquini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Pasquini. Silvia Pasquini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bedini, Annalida, Michele Retini, Laura Scalvini, et al.. (2024). Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence. Journal of Pineal Research. 76(2). e12941–e12941. 3 indexed citations
2.
Gianferrara, Teresa, Matteo Pavan, Davide Bassani, et al.. (2023). Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors. ChemMedChem. 18(14). e202300109–e202300109. 3 indexed citations
3.
Oliva, Paola, Silvia Pasquini, Veronica Salmaso, et al.. (2023). 2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators. ACS Medicinal Chemistry Letters. 14(12). 1640–1646.
4.
Contri, Chiara, Silvia Pasquini, Gabriele Carullo, et al.. (2023). Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents. Archiv der Pharmazie. 356(12). e2300410–e2300410. 4 indexed citations
5.
Merighi, Stefania, Alessia Travagli, Silvia Pasquini, et al.. (2023). Caffeine for Prevention of Alzheimer’s Disease: Is the A2A Adenosine Receptor Its Target?. Biomolecules. 13(6). 967–967. 18 indexed citations
6.
Vincenzi, Fabrizio, Silvia Pasquini, Chiara Contri, et al.. (2023). Pharmacology of Adenosine Receptors: Recent Advancements. Biomolecules. 13(9). 1387–1387. 16 indexed citations
7.
Fernández, Mercedes, Alessia Travagli, Silvia Pasquini, et al.. (2023). Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy. Pharmaceutics. 15(10). 2441–2441. 4 indexed citations
8.
Catarzi, Daniela, Flavia Varano, Fabrizio Melani, et al.. (2022). 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. Pharmaceuticals. 15(4). 478–478. 5 indexed citations
9.
Merighi, Stefania, Pier Andrea Borea, Katia Varani, et al.. (2022). Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease. Molecules. 27(9). 2680–2680. 18 indexed citations
10.
Gessi, Stefania, Tino Emanuele Poloni, Katia Varani, et al.. (2021). A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease. Cells. 10(9). 2344–2344. 23 indexed citations
11.
Merighi, Stefania, Tino Emanuele Poloni, Silvia Pasquini, et al.. (2021). An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?. Frontiers in Pharmacology. 12. 652455–652455. 15 indexed citations
12.
Vincenzi, Fabrizio, John Charles Rotondo, Silvia Pasquini, et al.. (2021). A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma. Frontiers in Oncology. 11. 679285–679285. 15 indexed citations
13.
Vincenzi, Fabrizio, Silvia Pasquini, Stefania Gessi, et al.. (2020). The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation. Cells. 9(5). 1242–1242. 10 indexed citations
14.
Varano, Flavia, Daniela Catarzi, Fabrizio Vincenzi, et al.. (2020). Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents. Bioorganic & Medicinal Chemistry Letters. 30(9). 127067–127067. 14 indexed citations
15.
Vincenzi, Fabrizio, Silvia Pasquini, Stefania Merighi, et al.. (2020). A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?. Frontiers in Pharmacology. 11. 625134–625134. 9 indexed citations
16.
Catarzi, Daniela, Flavia Varano, Matteo Falsini, et al.. (2019). Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity. Journal of Medicinal Chemistry. 62(15). 6894–6912. 18 indexed citations
17.
18.
Varano, Flavia, Daniela Catarzi, Matteo Falsini, et al.. (2018). Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1 and A2A adenosine receptor antagonists/inverse agonists. Bioorganic & Medicinal Chemistry. 26(12). 3688–3695. 14 indexed citations
19.
Catarzi, Daniela, Flavia Varano, Matteo Falsini, et al.. (2018). Development of novel pyridazinone-based adenosine receptor ligands. Bioorganic & Medicinal Chemistry Letters. 28(9). 1484–1489. 5 indexed citations
20.
Vincenzi, Fabrizio, Annalisa Ravani, Silvia Pasquini, et al.. (2016). Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron‐Like and Microglial Cells. Journal of Cellular Physiology. 232(5). 1200–1208. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roselyn B. Rose’Meyer Breakdown of academic impact, for papers by Violeta N. Mutafova–Yambolieva Breakdown of academic impact, for papers by Dan L. Li Breakdown of academic impact, for papers by Pawan Faris Breakdown of academic impact, for papers by Anthony Sharp Breakdown of academic impact, for papers by Junwei Zeng Breakdown of academic impact, for papers by Eva Irenius Breakdown of academic impact, for papers by Isabelle Pineau Breakdown of academic impact, for papers by Michael D. Lovelace Breakdown of academic impact, for papers by Patricia García‐Sanz
Rankless by CCL
2026